Global Nasal Drug Delivery Systems Market Research Report 2023

Publication ID:

PB502232055

Publication Date:

February 6, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. Intranasal Drug Delivery Devices are medical devices used for drug delivery through noses.
Highlights
The global Nasal Drug Delivery Systems market was valued at US$ 42310 million in 2022 and is anticipated to reach US$ 55780 million by 2029, witnessing a CAGR of 3.6% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Nasal Drug Delivery Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Nasal Drug Delivery Systems is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Nasal Drug Delivery Systems include Merck, GSK, AstraZeneca, Johnson & Johnson, BD, Pfizer, Baxter International, Bausch Health and Novartis, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Nasal Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nasal Drug Delivery Systems.
The Nasal Drug Delivery Systems market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nasal Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nasal Drug Delivery Systems manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Merck
GSK
AstraZeneca
Johnson & Johnson
BD
Pfizer
Baxter International
Bausch Health
Novartis
Segment by Type
Nasal Spray
Nasal Powders
Nasal Drops
Nasal Gels
Others
Segment by Application
Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Nasal Drug Delivery Systems manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Nasal Drug Delivery Systems in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Nasal Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Nasal Drug Delivery Systems
1.2 Nasal Drug Delivery Systems Segment by Type
1.2.1 Global Nasal Drug Delivery Systems Market Value Comparison by Type (2023-2029)
1.2.2 Nasal Spray
1.2.3 Nasal Powders
1.2.4 Nasal Drops
1.2.5 Nasal Gels
1.2.6 Others
1.3 Nasal Drug Delivery Systems Segment by Application
1.3.1 Global Nasal Drug Delivery Systems Market Value by Application: (2023-2029)
1.3.2 Hospitals Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Nasal Drug Delivery Systems Market Size Estimates and Forecasts
1.4.1 Global Nasal Drug Delivery Systems Revenue 2018-2029
1.4.2 Global Nasal Drug Delivery Systems Sales 2018-2029
1.4.3 Global Nasal Drug Delivery Systems Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nasal Drug Delivery Systems Market Competition by Manufacturers
2.1 Global Nasal Drug Delivery Systems Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nasal Drug Delivery Systems Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nasal Drug Delivery Systems Average Price by Manufacturers (2018-2023)
2.4 Global Nasal Drug Delivery Systems Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nasal Drug Delivery Systems, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nasal Drug Delivery Systems, Product Type & Application
2.7 Nasal Drug Delivery Systems Market Competitive Situation and Trends
2.7.1 Nasal Drug Delivery Systems Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nasal Drug Delivery Systems Players Market Share by Revenue
2.7.3 Global Nasal Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nasal Drug Delivery Systems Retrospective Market Scenario by Region
3.1 Global Nasal Drug Delivery Systems Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nasal Drug Delivery Systems Global Nasal Drug Delivery Systems Sales by Region: 2018-2029
3.2.1 Global Nasal Drug Delivery Systems Sales by Region: 2018-2023
3.2.2 Global Nasal Drug Delivery Systems Sales by Region: 2024-2029
3.3 Global Nasal Drug Delivery Systems Global Nasal Drug Delivery Systems Revenue by Region: 2018-2029
3.3.1 Global Nasal Drug Delivery Systems Revenue by Region: 2018-2023
3.3.2 Global Nasal Drug Delivery Systems Revenue by Region: 2024-2029
3.4 North America Nasal Drug Delivery Systems Market Facts & Figures by Country
3.4.1 North America Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nasal Drug Delivery Systems Sales by Country (2018-2029)
3.4.3 North America Nasal Drug Delivery Systems Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nasal Drug Delivery Systems Market Facts & Figures by Country
3.5.1 Europe Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nasal Drug Delivery Systems Sales by Country (2018-2029)
3.5.3 Europe Nasal Drug Delivery Systems Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nasal Drug Delivery Systems Market Facts & Figures by Country
3.6.1 Asia Pacific Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nasal Drug Delivery Systems Sales by Country (2018-2029)
3.6.3 Asia Pacific Nasal Drug Delivery Systems Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nasal Drug Delivery Systems Market Facts & Figures by Country
3.7.1 Latin America Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nasal Drug Delivery Systems Sales by Country (2018-2029)
3.7.3 Latin America Nasal Drug Delivery Systems Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nasal Drug Delivery Systems Market Facts & Figures by Country
3.8.1 Middle East and Africa Nasal Drug Delivery Systems Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nasal Drug Delivery Systems Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nasal Drug Delivery Systems Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Nasal Drug Delivery Systems Sales by Type (2018-2029)
4.1.1 Global Nasal Drug Delivery Systems Sales by Type (2018-2023)
4.1.2 Global Nasal Drug Delivery Systems Sales by Type (2024-2029)
4.1.3 Global Nasal Drug Delivery Systems Sales Market Share by Type (2018-2029)
4.2 Global Nasal Drug Delivery Systems Revenue by Type (2018-2029)
4.2.1 Global Nasal Drug Delivery Systems Revenue by Type (2018-2023)
4.2.2 Global Nasal Drug Delivery Systems Revenue by Type (2024-2029)
4.2.3 Global Nasal Drug Delivery Systems Revenue Market Share by Type (2018-2029)
4.3 Global Nasal Drug Delivery Systems Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nasal Drug Delivery Systems Sales by Application (2018-2029)
5.1.1 Global Nasal Drug Delivery Systems Sales by Application (2018-2023)
5.1.2 Global Nasal Drug Delivery Systems Sales by Application (2024-2029)
5.1.3 Global Nasal Drug Delivery Systems Sales Market Share by Application (2018-2029)
5.2 Global Nasal Drug Delivery Systems Revenue by Application (2018-2029)
5.2.1 Global Nasal Drug Delivery Systems Revenue by Application (2018-2023)
5.2.2 Global Nasal Drug Delivery Systems Revenue by Application (2024-2029)
5.2.3 Global Nasal Drug Delivery Systems Revenue Market Share by Application (2018-2029)
5.3 Global Nasal Drug Delivery Systems Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Nasal Drug Delivery Systems Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Description and Business Overview
6.2.3 GSK Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GSK Nasal Drug Delivery Systems Product Portfolio
6.2.5 GSK Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Corporation Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.3.4 AstraZeneca Nasal Drug Delivery Systems Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Johnson & Johnson Nasal Drug Delivery Systems Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 BD
6.5.1 BD Corporation Information
6.5.2 BD Description and Business Overview
6.5.3 BD Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.5.4 BD Nasal Drug Delivery Systems Product Portfolio
6.5.5 BD Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Pfizer Nasal Drug Delivery Systems Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Baxter International
6.6.1 Baxter International Corporation Information
6.6.2 Baxter International Description and Business Overview
6.6.3 Baxter International Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Baxter International Nasal Drug Delivery Systems Product Portfolio
6.7.5 Baxter International Recent Developments/Updates
6.8 Bausch Health
6.8.1 Bausch Health Corporation Information
6.8.2 Bausch Health Description and Business Overview
6.8.3 Bausch Health Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Bausch Health Nasal Drug Delivery Systems Product Portfolio
6.8.5 Bausch Health Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Nasal Drug Delivery Systems Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Novartis Nasal Drug Delivery Systems Product Portfolio
6.9.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nasal Drug Delivery Systems Industry Chain Analysis
7.2 Nasal Drug Delivery Systems Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nasal Drug Delivery Systems Production Mode & Process
7.4 Nasal Drug Delivery Systems Sales and Marketing
7.4.1 Nasal Drug Delivery Systems Sales Channels
7.4.2 Nasal Drug Delivery Systems Distributors
7.5 Nasal Drug Delivery Systems Customers
8 Nasal Drug Delivery Systems Market Dynamics
8.1 Nasal Drug Delivery Systems Industry Trends
8.2 Nasal Drug Delivery Systems Market Drivers
8.3 Nasal Drug Delivery Systems Market Challenges
8.4 Nasal Drug Delivery Systems Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Merck
GSK
AstraZeneca
Johnson & Johnson
BD
Pfizer
Baxter International
Bausch Health
Novartis

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂